NCT04155333

Brief Summary

Non-invasive brain stimulation has been shown to alter performance in both clinical and healthy populations on cognitive tasks. While the performance alterations have generally been shown to result in enhancement, mixed results remain in the literature. Much of the mixed results within the literature have been attributed to the use of different stimulation parameters, targeting of different brain areas, and using a variety of performance measures or assessing different constructs. However, non-invasive brain stimulation is a desirable method for enhancing Soldier performance given the ease of administration and minimal side effects as compared to other forms of performance enhancement (e.g., pharmaceuticals, caffeine). The objective of the current study is to evaluate the effects of non-invasive brain stimulation to the left dorsolateral prefrontal cortex in enhancing Soldier cognitive skills and performance on military tasks. A double blind within-subjects design will be used with healthy, rested Soldiers who will receive non-invasive brain stimulation and perform basic cognitive and operationally relevant tasks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 7, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

December 12, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

January 25, 2022

Status Verified

January 1, 2022

Enrollment Period

1.5 years

First QC Date

November 5, 2019

Last Update Submit

January 24, 2022

Conditions

Outcome Measures

Primary Outcomes (7)

  • Military task performance

    Patrol exertion multitask

    Folllowing stimulation; task lasts approximately 20 min

  • Military task performance

    Target acquisition

    Folllowing stimulation; task lasts approximately 40 min

  • Cognitive function - Selective Attention

    Stroop test

    Approximately 3 minutes during stimulation

  • Cognitive function - Multitasking/Working Memory

    Dual n-back

    Approximately 5 minutes during stimulation

  • Cognitive function - Working Memory

    Digit span task

    Approximately 2 minutes during stimulation

  • Cognitive function - Sustained attention

    Rapid Visual Information Processing Task

    Approximately 7 minutes during stimulation

  • Cognitive function - Executive function

    Shifting Attention Task: Digit symbol substitution task

    Approximately 2 minutes during stimulation

Secondary Outcomes (3)

  • Cognitive function - Impulsivity/Motor Control

    Approximately 3 minutes after stimulation

  • Cognitive function - Risk Taking/ Decision Making

    Approximately 1 minute after stimulation

  • Cognitive function - Cognitive Flexibility

    Approximately 5 minutes after stimulation

Other Outcomes (7)

  • Confounding factor - Sleepiness

    Approximately 1 minute, before and after stimulation

  • Confounding factor - Circadian typology

    Approximately 15 minutes during intake

  • Moderator variable - Intelligence

    Approximately 15 minutes during intake

  • +4 more other outcomes

Study Arms (3)

Active anodal stimulation

EXPERIMENTAL

active anodal stimulation at F3, cathode placed on contralateral bicep

Device: Transcranial direct current stimulation

Active cathodal stimulation

EXPERIMENTAL

active cathodal stimulation at F3, anode placed on contralateral bicep

Device: Transcranial direct current stimulation

Sham stimulation

SHAM COMPARATOR

sham stimulation that will be counterbalanced between subjects such that half will receive sham stimulation configured as condition 1 (anode F3, cathode bicep) and half will receive condition 2 (cathode F3, anode bicep)

Device: Transcranial direct current stimulation

Interventions

Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that stimulates the brain through the application of a low-intensity electrical current, typically ranging from 1 to 2 milliamps (mA), via electrodes placed on an individual's scalp. During the active stimulation sessions, 2 mA of stimulation will be applied for 30 minutes. During the sham stimulation session, 2 mA of stimulation will be applied over the course of 90 sec, the electrodes will remain in place for the 30 minute duration.

Active anodal stimulationActive cathodal stimulationSham stimulation

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Must be 18 (if active duty), 19 (if non-active duty) up to 40 years old.
  • Must have normal hearing, vision or corrected to normal vision, and cognitive function as determined by self-report and screening by study physician
  • Must have obtained at minimum 6 hours of sleep prior to data collection, as assessed by actigraphy data and self-report.
  • Must have refrained from consumption of caffeine, 16 hours, nicotine, 2 hours, and alcohol, 24 hours, prior to the study, assessed by self-report.

You may not qualify if:

  • Haven taken any medications which induce drowsiness, such as over-the-counter antihistamines within 24 hours of participation in the study. Any self-medication will be assessed through self-report
  • No current medical conditions or medications affecting cognitive function or attention.
  • Any history of any attention deficit condition requiring medication.
  • Any history of psychological/psychiatric disorder.
  • Any history of seizures, migraines, or neurological disorders.
  • History of a head injury involving loss of consciousness.
  • Any metal implanted within the head (e.g., shrapnel, surgical clips) or any implanted devices (e.g., cardiac pacemaker, brain stimulator, hydrocephalic shunt).
  • Skin condition on the scalp, such as psoriasis or eczema, or wounds on the head.
  • Currently receiving hormonal therapy treatments, other than birth control or as determined by physicians.
  • Potential for caffeine withdrawal symptoms that will impede cognitive testing.
  • Females with a known pregnancy, who test positively for pregnancy, or refuse the test will be excluded, given the lack of available research regarding the effects of tDCS during pregnancy. Known pregnancy will be assessed during screening, females without a known pregnancy will be requested to provide a urine sample during the screening procedures to ensure the absence of pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

U.S. Army Aeromedical Research Laboratory

Fort Rucker, Alabama, 36362, United States

Location

MeSH Terms

Interventions

Transcranial Direct Current Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Katie Feltman, PhD

    US Army Aeromedical Research Laboratory

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Subjects and the research team will both be blind to the stimulation condition delivered at each test session. Access will be limited to the study physicians, investigators, and device programmers.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: A double-blind, randomized, sham-controlled, within-subjects design
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2019

First Posted

November 7, 2019

Study Start

December 12, 2019

Primary Completion

June 1, 2021

Study Completion

September 30, 2021

Last Updated

January 25, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations